BENEFERON Trademark

Trademark Overview

On Wednesday, April 19, 2000, a trademark application was filed for BENEFERON with the United States Patent and Trademark Office. The USPTO has given the BENEFERON trademark a serial number of 76029207. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 21, 2012. This trademark is owned by Schering Aktiengesellschaft. The BENEFERON trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS, NAMELY, CYTOKINES AND IMMUNO-THERAPEUTICS
beneferon

General Information

Serial Number76029207
Word MarkBENEFERON
Filing DateWednesday, April 19, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 21, 2012
Registration Number2963571
Registration DateTuesday, June 28, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 5, 2005

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS, NAMELY, CYTOKINES AND IMMUNO-THERAPEUTICS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 21, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Party Type31 - New Owner After Registration
Legal Entity Type07 - Unincorporated Association
AddressBERLIN 13353
DE
Party NameSchering Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressD-13342 Berlin
DE
Party NameSchering Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressD-13342 Berlin
DE
Party NameSchering Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressD-13342 Berlin
DE

Trademark Events

Event DateEvent Description
Friday, September 21, 2012CANCELLED SEC. 8 (6-YR)
Wednesday, July 18, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 28, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, April 5, 2005PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2005NOTICE OF PUBLICATION
Friday, January 7, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 19, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 15, 2004ASSIGNED TO LIE
Wednesday, October 6, 2004AMENDMENT FROM APPLICANT ENTERED
Friday, September 17, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2004FAX RECEIVED
Thursday, August 26, 2004LETTER OF SUSPENSION MAILED
Wednesday, August 25, 2004PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, August 25, 2004NOTICE OF ALLOWANCE CANCELLED
Tuesday, August 3, 2004PETITION TO DIRECTOR - GRANTED
Friday, April 9, 2004PETITION TO DIRECTOR RECEIVED
Monday, April 19, 2004EXTENSION 3 GRANTED
Tuesday, March 30, 2004EXTENSION 3 FILED
Wednesday, April 14, 2004CASE FILE IN TICRS
Friday, April 9, 2004PAPER RECEIVED
Friday, April 2, 2004PAPER RECEIVED
Friday, November 7, 2003EXTENSION 2 GRANTED
Tuesday, September 30, 2003EXTENSION 2 FILED
Friday, October 3, 2003PAPER RECEIVED
Thursday, May 22, 2003EXTENSION 1 GRANTED
Monday, March 31, 2003EXTENSION 1 FILED
Monday, March 31, 2003PAPER RECEIVED
Tuesday, October 1, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2002PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2002NOTICE OF PUBLICATION
Saturday, May 4, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 29, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 10, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 28, 2000LETTER OF SUSPENSION MAILED
Friday, August 25, 2000ASSIGNED TO EXAMINER

Related Keywords

beneferon immuno therapeutics cytokines namely preparations pharmaceutical